ANI Average Assets vs Accounts Payable Analysis

ANIP Stock  USD 69.69  0.14  0.20%   
Trend analysis of ANI Pharmaceuticals balance sheet accounts such as Other Current Liab of 104.8 M, Total Current Liabilities of 152.8 M or Total Stockholder Equity of 454.4 M provides information on ANI Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of ANI Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using ANI Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.

About ANI Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of ANI Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. ANI Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ANI Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ANI currently owns. An asset can also be divided into two categories, current and non-current.

ANI Pharmaceuticals Balance Sheet Chart

ANI Pharmaceuticals Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how ANI Pharmaceuticals uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, ANI Pharmaceuticals' Cash is relatively stable compared to the past year. As of 03/28/2024, Non Current Assets Total is likely to grow to about 404 M, while Common Stock is likely to drop 1,900.

Total Assets

Total assets refers to the total amount of ANI Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ANI Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on ANI Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ANI Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from ANI Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ANI Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.As of 03/28/2024, Selling General Administrative is likely to grow to about 157.9 M, while Discontinued Operations is likely to drop slightly above 156 K.
 2021 2022 2023 2024 (projected)
Gross Profit115.5M177.6M245.5M257.8M
Total Revenue216.1M316.4M486.8M511.2M

ANI Pharmaceuticals fundamental ratios Correlations

0.950.841.00.90.70.160.940.60.950.6-0.480.930.531.00.960.95-0.480.980.97-0.190.090.680.920.970.09
0.950.870.950.880.610.060.970.580.870.58-0.380.840.610.940.950.93-0.380.940.89-0.24-0.090.680.850.960.14
0.840.870.830.860.650.160.810.430.820.43-0.370.770.480.850.850.77-0.370.790.82-0.06-0.170.680.650.83-0.09
1.00.950.830.880.640.150.940.660.920.66-0.480.930.560.980.950.96-0.480.990.96-0.150.120.720.920.950.15
0.90.880.860.880.830.260.830.320.950.32-0.480.790.430.920.940.76-0.480.850.91-0.26-0.220.440.810.9-0.09
0.70.610.650.640.830.320.56-0.130.88-0.13-0.460.610.160.740.740.44-0.460.620.74-0.26-0.110.170.660.75-0.46
0.160.060.160.150.260.32-0.06-0.040.27-0.04-0.890.3-0.010.170.080.04-0.890.180.260.40.330.160.020.05-0.18
0.940.970.810.940.830.56-0.060.620.830.62-0.310.80.650.930.960.94-0.310.930.89-0.38-0.120.650.890.960.22
0.60.580.430.660.32-0.13-0.040.620.341.0-0.190.630.460.550.470.81-0.190.650.520.10.350.750.520.470.61
0.950.870.820.920.950.880.270.830.340.34-0.520.860.390.960.930.79-0.520.90.95-0.190.030.520.870.93-0.16
0.60.580.430.660.32-0.13-0.040.621.00.34-0.190.630.460.550.470.81-0.190.650.520.10.350.750.520.470.61
-0.48-0.38-0.37-0.48-0.48-0.46-0.89-0.31-0.19-0.52-0.19-0.57-0.33-0.48-0.41-0.391.0-0.53-0.58-0.21-0.33-0.41-0.39-0.40.01
0.930.840.770.930.790.610.30.80.630.860.63-0.570.460.910.820.89-0.570.930.920.090.350.730.840.840.11
0.530.610.480.560.430.16-0.010.650.460.390.46-0.330.460.50.560.6-0.330.620.61-0.38-0.160.670.590.550.14
1.00.940.850.980.920.740.170.930.550.960.55-0.480.910.50.970.92-0.480.970.97-0.220.060.640.920.970.05
0.960.950.850.950.940.740.080.960.470.930.47-0.410.820.560.970.89-0.410.940.94-0.34-0.160.550.910.980.08
0.950.930.770.960.760.440.040.940.810.790.81-0.390.890.60.920.89-0.390.960.89-0.170.140.770.870.90.34
-0.48-0.38-0.37-0.48-0.48-0.46-0.89-0.31-0.19-0.52-0.191.0-0.57-0.33-0.48-0.41-0.39-0.53-0.58-0.21-0.33-0.41-0.39-0.40.01
0.980.940.790.990.850.620.180.930.650.90.65-0.530.930.620.970.940.96-0.530.97-0.170.140.730.930.950.18
0.970.890.820.960.910.740.260.890.520.950.52-0.580.920.610.970.940.89-0.580.97-0.20.090.670.920.940.01
-0.19-0.24-0.06-0.15-0.26-0.260.4-0.380.1-0.190.1-0.210.09-0.38-0.22-0.34-0.17-0.21-0.17-0.20.570.11-0.38-0.350.12
0.09-0.09-0.170.12-0.22-0.110.33-0.120.350.030.35-0.330.35-0.160.06-0.160.14-0.330.140.090.570.350.07-0.070.08
0.680.680.680.720.440.170.160.650.750.520.75-0.410.730.670.640.550.77-0.410.730.670.110.350.550.590.09
0.920.850.650.920.810.660.020.890.520.870.52-0.390.840.590.920.910.87-0.390.930.92-0.380.070.550.920.1
0.970.960.830.950.90.750.050.960.470.930.47-0.40.840.550.970.980.9-0.40.950.94-0.35-0.070.590.920.06
0.090.14-0.090.15-0.09-0.46-0.180.220.61-0.160.610.010.110.140.050.080.340.010.180.010.120.080.090.10.06
Click cells to compare fundamentals

ANI Pharmaceuticals Account Relationship Matchups

ANI Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets456.8M461.2M771.6M760.1M904.4M949.6M
Other Current Liab36.7M54.0M63.6M69.3M99.8M104.8M
Total Current Liabilities61.7M78.6M87.5M99.4M145.5M152.8M
Total Stockholder Equity212.8M195.7M358.7M338.5M432.7M454.4M
Property Plant And Equipment Net40.6M41.3M52.7M43.2M44.6M46.8M
Net Debt123.4M177.8M187.1M238.3M94.2M98.9M
Retained Earnings17.6M(5.0M)(47.8M)(97.3M)(80.1M)(84.1M)
Accounts Payable14.6M11.3M23.0M29.3M36.7M38.5M
Cash62.3M7.9M100.3M48.2M221.1M232.2M
Non Current Assets Total269.1M290.9M449.8M415.8M384.8M404.0M
Cash And Short Term Investments62.3M7.9M100.3M48.2M221.1M232.2M
Common Stock Shares Outstanding12.0M12.0M12.6M16.3M18.2M19.1M
Liabilities And Stockholders Equity456.8M461.2M771.6M760.1M904.4M949.6M
Other Current Assets5.1M5.9M11.3M8.4M25.2M26.5M
Total Liab244.0M265.5M412.9M421.5M471.7M495.3M
Property Plant And Equipment Gross40.6M41.3M75.6M76.0M77.5M81.4M
Total Current Assets187.7M170.3M321.8M344.3M519.6M545.6M
Other Stockholder Equity200.1M212.1M384.7M398.8M479.2M503.1M
Accumulated Other Comprehensive Income(4.9M)(11.4M)(3.1M)12.2M8.9M9.3M
Short Long Term Debt Total185.7M185.7M287.4M286.5M315.3M331.1M
Short Term Debt115.7M9.9M13.2M850K977.5K928.6K
Current Deferred Revenue451K80K87K8.2M9.4M9.9M
Non Currrent Assets Other1.2M802K2.2M2.6M12.3M12.9M
Non Current Liabilities Total182.3M186.9M325.3M322.1M326.2M342.5M
Net Receivables72.1M95.8M128.5M165.4M162.1M170.2M
Net Tangible Assets28.8M3.6M36.7M58.7M52.8M55.5M
Other Assets44.6M57.5M75.1M92.7M106.6M112.0M
Long Term Debt175.8M172.4M286.5M285.7M284.8M149.2M
Retained Earnings Total Equity17.6M(5.0M)(47.8M)(97.3M)(111.9M)(117.5M)
Inventory48.2M60.8M81.7M105.4M111.2M116.8M
Deferred Long Term Liab1.5M800K500K600K690K458.1K
Intangible Assets180.4M188.5M294.1M251.6M209.0M156.5M
Property Plant Equipment40.6M41.3M52.7M43.2M49.7M52.2M
Capital Surpluse200.8M214.4M387.8M403.9M464.5M237.5M
Other Liab7K201K31.0M35.1M40.3M42.3M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ANI Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ANI Pharmaceuticals' short interest history, or implied volatility extrapolated from ANI Pharmaceuticals options trading.

Pair Trading with ANI Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ANI Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with ANI Stock

  0.7MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
  0.79EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against ANI Stock

  0.94KA Kineta Inc Report 29th of March 2024 PairCorr
  0.77MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.73MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.72MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.71MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
The ability to find closely correlated positions to ANI Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ANI Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ANI Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ANI Pharmaceuticals to buy it.
The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ANI Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ANI Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ANI Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether ANI Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ANI Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ani Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Ani Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ANI Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in ANI Stock, please use our How to Invest in ANI Pharmaceuticals guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for ANI Stock analysis

When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Money Managers
Screen money managers from public funds and ETFs managed around the world
Is ANI Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ANI Pharmaceuticals. If investors know ANI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ANI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.89)
Earnings Share
0.85
Revenue Per Share
27.044
Quarterly Revenue Growth
0.397
Return On Assets
0.0372
The market value of ANI Pharmaceuticals is measured differently than its book value, which is the value of ANI that is recorded on the company's balance sheet. Investors also form their own opinion of ANI Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ANI Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ANI Pharmaceuticals' market value can be influenced by many factors that don't directly affect ANI Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ANI Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ANI Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ANI Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.